Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Procter and Gamble Co | 62 |
| 2 | Sanofi SA | 42 |
| 3 | Bristol Myers Squibb Co | 39 |
| 4 | Pfizer Inc | 31 |
| 5 | Meiji Holdings Co Ltd | 28 |
| 6 | Notable Labs Ltd | 28 |
| 7 | GSK PLC | 25 |
| 8 | BASF SE | 23 |
| 9 | Shionogi and Co Ltd | 23 |
| 10 | Roche Holding AG | 22 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07D | Heterocyclic compounds | 438 |
| 2 | A61P | Therapeutic activity (drug indications) | 292 |
| 3 | C07C | Acyclic and carbocyclic compounds | 182 |
| 4 | A61K | Medicinal preparations | 179 |
| 5 | G01N | Investigating / analysing materials | 144 |
| 6 | Y02P | Climate change mitigation: production | 140 |
| 7 | C07J | 127 | |
| 8 | C07F | Organometallic compounds | 87 |
| 9 | D21H | 77 | |
| 10 | C08F | Polymers from C=C unsaturated bonds | 74 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Use of girard t reagent in quantitative aliphatic n-aldehyde determinations | 1965 | 1 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Yuqin Wang | Swansea University | 3 |
| 2 | William J. Griffiths | Swansea University | 3 |
| 3 | Linjuan Huang | Northwest University | 3 |
| 4 | Zhongfu Wang | Northwest University | 3 |
| 5 | Mohsen M. Mostafa | Mansoura University | 3 |
| 6 | Peter J. Crick | Swansea University | 3 |
| 7 | Chengjian Wang | Northwest University | 3 |
| 8 | Shuichi Shimma | The University of Osaka | 2 |
| 9 | Yiannis S. Angelis | National Centre of Scientific Research "Demokritos" | 2 |
| 10 | Shoujiro Ogawa | Tokyo University of Science | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Derivatization with Girard Reagent T Combined with LC−MS/MS for the Sensitive Detection of 5-Formyl-2‘-deoxyuridine in Cellular DNA | 2006 | 99 | DNA Repair Mechanisms |
| Derivatization Strategies for the Detection of Triamcinolone Acetonide in Cartilage by Using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging | 2016 | 86 | Mass Spectrometry Techniques and Applications |
| Reactions of Microsolvated Organic Compounds at Ambient Surfaces: Droplet Velocity, Charge State, and Solvent Effects | 2012 | 84 | Mass Spectrometry Techniques and Applications |
| Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans | 2018 | 64 | Glycosylation and Glycoproteins Research |
| Microscopic visualization of testosterone in mouse testis by use of imaging mass spectrometry | 2016 | 64 | Pharmacogenetics and Drug Metabolism |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical composition and molecular weight of Girard-T reagent?
Which organizations hold the most patents involving Girard-T reagent?
What are the main research topics associated with Girard-T reagent in recent academic literature?
Who are the most prolific academic authors publishing on Girard-T reagent applications?
What patent technology areas dominate intellectual property filings involving Girard-T reagent?